Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

The market is just becoming aware of the tremendous potential that the company's patented MANF technology has to offer.

The company's management is doing an excellent job of bringing well known and respected individuals on board to help guide them in making the company a tremendous commercial and financial success for its shareholders.

Take the time to read about the individuals who are on the company's advisory board:

http://www.amarantus.com/about-us/corporate-advisory-board.html


A "big pharma" development partnership in 2013 takes this above $1.00. It's only a matter of time before it happens.

The shorts need millions of shares to cover with no where to find them. Hold on to your cheap shares. AMBS is tremendously undervalued.

Interesting months ahead for the shareholders.

p.s. In its beginning Amgen (AMGN) was trading in the eight cents price range. Today it is trading at almost $90.00. Don't think it can't happen here.